Low SMAD4 expression significantly correlated with the clinical stage (P = 0.004), tumor size (P = 0.020), and lymph node metastasis (P = 0.041; Figures 3B–G and Supplementary Table 6). This evidence concerns the gene SMAD4 and metastatic malignant neoplasm in the lymph nodes.